Interactions of beta-adrenoceptor agonists and antagonists with the 5-hydroxytryptamine2 (5-HT2) receptor
- PMID: 6136009
- DOI: 10.1016/0028-3908(83)90159-4
Interactions of beta-adrenoceptor agonists and antagonists with the 5-hydroxytryptamine2 (5-HT2) receptor
Abstract
The effect of beta-adrenoceptor agonists and antagonists on the binding of [3H]-spiperone in the frontal cortex of the rat has been examined to determine their possible interaction with the 5-hydroxytryptamine2 (5-HT2) receptor. Methysergide and the putative 5-HT2 antagonist, pirenperone, had IC50 values in the low nanomolar range whilst 5-HT and quipazine had micromolar IC50 values. Non-selective beta-adrenoceptor antagonists ((-)-propranolol, (-)-alprenolol) had similar IC50 values to 5-HT whilst selective (beta 1- or beta 2-)antagonists, (+)-propranolol and the beta-adrenoceptor agonists, clenbuterol and dobutamine, had values at least ten-fold higher. It is suggested that inhibition of 5-HT-mediated behaviour by non-selective beta-adrenoceptor antagonists results from their action at 5-HT2 receptors while clenbuterol does not enhance 5-HT-mediated behaviours by acting at this site.
Similar articles
-
Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.J Pharmacol Exp Ther. 1984 Mar;228(3):628-35. J Pharmacol Exp Ther. 1984. PMID: 6707913
-
Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release.Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(3):165-70. doi: 10.1007/BF00505480. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 7155196
-
A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.Br J Pharmacol. 1985 Mar;84(3):743-53. doi: 10.1111/j.1476-5381.1985.tb16157.x. Br J Pharmacol. 1985. PMID: 2580582 Free PMC article.
-
Central serotonergic receptors: evidence for heterogeneity and characterization by ligand-binding.Neurosci Biobehav Rev. 1982 Winter;6(4):499-502. doi: 10.1016/0149-7634(82)90031-8. Neurosci Biobehav Rev. 1982. PMID: 6757812 Review.
-
Aspects of the pharmacology of beta-adrenoceptor agonists and antagonists.Acta Anaesthesiol Scand Suppl. 1982;76:12-9. doi: 10.1111/j.1399-6576.1982.tb01884.x. Acta Anaesthesiol Scand Suppl. 1982. PMID: 6152879 Review.
Cited by
-
Depolarization-induced release of propranolol and atenolol from rat cortical synaptosomes.Br J Pharmacol. 1985 Feb;84(2):499-510. doi: 10.1111/j.1476-5381.1985.tb12934.x. Br J Pharmacol. 1985. PMID: 3919793 Free PMC article.
-
Lesions of the serotonergic system impair the facilitation of but not the tolerance to the effects of chronic clenbuterol administration.Psychopharmacology (Berl). 1987;91(4):496-9. doi: 10.1007/BF00216017. Psychopharmacology (Berl). 1987. PMID: 2438713
-
The modulation of head-twitch behaviour by drugs acting on beta-adrenoceptors: evidence for the involvement of both beta 1- and beta 2-adrenoceptors.Psychopharmacology (Berl). 1986;88(3):320-4. doi: 10.1007/BF00180832. Psychopharmacology (Berl). 1986. PMID: 2870532
-
Effects of salbutamol upon performance on an operant screen for antidepressants.Psychopharmacology (Berl). 1993;113(1):1-10. doi: 10.1007/BF02244325. Psychopharmacology (Berl). 1993. PMID: 7862813
-
Central beta-adrenoceptors can modulate 5-hydroxytryptamine-induced tremor in rats.Br J Pharmacol. 1986 Feb;87(2):403-8. doi: 10.1111/j.1476-5381.1986.tb10830.x. Br J Pharmacol. 1986. PMID: 2869814 Free PMC article.